Halo340B Launches Innovative AI-Powered Platform to Strengthen 340B Compliance and Optimize Revenue for Healthcare Providers

WILLIAMSON, W.Va.--(BUSINESS WIRE)--Today marks the official launch of Halo340B (www.halo340b.com), a next-generation AI technology platform designed to transform how healthcare organizations manage the 340B Drug Pricing Program. By delivering a seamless, automated solution, Halo340B eliminates the complexities of program compliance while uncovering missed opportunities to significantly increase revenue for covered entities.

For years, covered entities—including health centers, hospitals, rural referral centers, and other program participants—have struggled to keep up with audits, evolving state Medicaid rules, contract pharmacy third-party administrator agreements, data management and system configurations, state transparency reporting requirements, and manufacturer restrictions on 340B claims. These challenges create a significant administrative burden. As a result, the fear of non-compliance penalties often leads organizations to adopt overly conservative practices, leaving millions of dollars in eligible 340B savings and revenue unrealized.

Halo340B was developed to reduce this administrative burden. Leveraging advanced machine learning and AI, the platform integrates seamlessly with existing Electronic Health Record (EHR) and pharmacy management systems. With minimal IT effort required, it operates in the background to automatically cross-reference patient data, provider eligibility, and medication dispensing records in real time.

Steven Zielinski, RPH, Executive Healthcare & Compliance Advisor, states: “In my years advising covered entities on 340B strategy, I have never seen a technology that addresses such a wide range of needs—from Medicare Fair Payment solutions to rebate management—while also adapting to ongoing industry changes. Halo340B™ is raising the bar for what compliance-driven, outcome-based technology should look like in this space.”

“The 340B program is a critical lifeline for healthcare providers serving vulnerable populations, but the administrative burden of compliance has become overwhelming,” said Jody Gooslin, Founder of Halo340B. “With our AI-driven platform, we remove the guesswork and heavy lifting. Halo340B provides a seamless, plug-and-play solution that not only ensures audit readiness but also captures lost revenue safely. We enable providers to stop worrying about compliance and focus on what matters most: patient care.”

Key Benefits of the Halo 340B Platform Include:

- Bulletproof Compliance: AI-powered, real-time auditing prevents duplicate discounts, diversion, and compliance breaches before they occur, ensuring full readiness for HRSA audits.

- Revenue Maximization: Proprietary algorithms analyze both historical and current data to identify and capture previously missed 340B-eligible claims, directly improving financial performance.

- Seamless Integration: A frictionless, plug-and-play deployment that works alongside major EHR and pharmacy systems with minimal training or workflow disruption—fully operational within weeks.

- Actionable Analytics: Intuitive dashboards provide executives and pharmacy leaders with clear insights into program performance, manufacturer restrictions, and financial growth.

As regulatory scrutiny increases and manufacturer restrictions continue to evolve, Halo 340B provides an intelligent safety net that transforms 340B management from a high-risk administrative burden into a streamlined revenue center.

To learn more about the platform or request a demo, visit www.halo340b.com.

About Halo340B

Halo340B is an AI-native healthcare technology company dedicated to simplifying the 340B Drug Pricing Program through advanced artificial intelligence. By delivering a secure, seamless, and fully compliant software platform, Halo 340B empowers covered entities to maximize program revenue, reduce audit risks, and extend critical resources to reach more eligible patients.